Governor Gary Herbert

now browsing by tag

 
 

August 8th 2016

aug8Today marks the last day before the deeming regulations kick in. As of tomorrow, the landscape of the vapor industry as we know it changes dramatically. This is just a snapshot of what this means for our beloved industry:

  • Vapor businesses are being forced to lie to consumers and are not allowed to make any claims through advertising, public statements, or their customers that these products are at least 95% less harmful, have fewer or no additives, has no tar or carbon monoxide when compared to other tobacco products. This ONLY applies to businesses though so for the consumers, keep preaching the truth because you are now the only voice of truth we have.
  • Shops, manufacturers and advocacy organizations are no longer allowed to give away free samples to the consumers; this applies to flavor sampling and giving away free product via rewards (“Buy 2 get 1” IS acceptable however). Customers MUST pay for sampling BEFORE you can sample a new flavor. For our retailers, you will need a SKU set up in you POS where you can record and show evidence of the charge. If you are a consumer, today August 7th, is the last day you can sample without paying so get out there TODAY and support your local vape shops to try as many of the new lines that have been introduced in the last few months.
  • No new products, improvements to existing products or innovations may be introduced to the market. This means:
    • No new liquids that were not previously sold or marketed prior to August 8th can be introduced.
    • Retailers must stop building coils & changing cotton
    • Retailers cannot teach a customer how to assemble their device and use it safely, fill their tanks, drip e-liquid on cotton or offer a repair service.
  • All retailers MUST check your government issued photo ID for EVERY customer who appears under the age of 27 – no exceptions. Even if you are a customer who has frequented the location for years, you must produce your ID for every single transaction if you appear under 27.

We know this is a difficult time for everyone and as of Monday, our retailers and manufacturers will be officially entering into a new time of uncertainty. We ask all consumers to remain patient with the businesses while they work to ensure they meet all the necessary regulations. There is still much work to be done on their side to meet the upcoming further deadlines so please be understanding. We would like to ask all consumers to funnel their frustration towards the federal fight. There are a few things you can do to help:

  1. Visit august8th.org to fill out the form and urge your federal representatives to support HR2058 and the Cole/Bishop Amendment.
  2. Participate in the #WeAreVapor call to action by taking a photo in front of your favorite shop and posting to social media and tagging your federal representatives http://utsmokefree.org/2016/07/vta-consumer/
  3. Support the Right2Be Smoke Free Coalition by donating money to help fund the lawsuit against the FDA https://www.r2bsmokefree.org/donations/fda-contribution/
  4. Every vapor business should be supporting advocacy through joining or financially supporting an organization of your choice who helps fight the local battles. There are national organizations such as SFATA, CASAA, AVA, and VTA who are focused heavily on the national FDA fight and they need & deserve your support too.

We ask all customers to please NOT get angry at your retailer as they must do all this to follow federal laws to avoid stiff penalties. This is NOT the time to give up but you should NOT stay calm. We must work TOGETHER instead of against one another and focus our attention on the preservation of the industry that each one of you fought hard to build. Write your congressman, send in letters to the editor of your local papers, donate money to the cause but do not just sit back expecting advocates to fight the fight. This is a time that our #VapeFam must come together to fight. This is a battle that will take EVERYONE to participate in to help win back the industry that was founded to save lives….#ABillionLives

Facebooktwitterby feather
rssby feather

Society For The Study Of Addiction

ssa

The Society For The Study Of Addiction has released a study titled “A framework for evaluating the public health impact of e-cigarettes and other vaporized nicotine products” which contains the following conclusions:

  • In the US, increasing e-cigarette use has been accompanied by an unusually large reduction in adult and youth smoking prevalence.
  • These products expose users to substantially lower levels of toxicants than combustible cigarettes.
  • A multi-criteria decision analysis estimated that exclusive VNP use is associated with 5% of the mortality risks of smoking. This is comparable to the estimated risks of low-nitrosamine smokeless tobacco.
  • Studies using major biomarkers of cancer and other chemicals in e-cigarettes indicate substantially lower (e.g. 9–450 times) levels compared to cigarette smoke.
  • For dual users, VNP use may translate to a lower quantity and duration of cigarettes smoked. Both may decrease lung cancer and chronic obstructive pulmonary disease (COPD) risk.
  • The potential to reduce risk is likely to depend upon the age of initial dual use. Although much use now begins at later ages, VNP use is likely to occur at earlier ages in more recent cohorts of smokers, and thereby provide a greater reduction in cigarette use and toxic exposures over longer periods of use.
  • Initiating VNP use before cigarette smoking may delay or prevent smoking initiation and thereby reduce smoking risks.
  • The population health impact depends critically upon whether the never smoker who tries VNPs would have smoked cigarettes in the absence of VNPs.
  • Studies of youth and young adult use from the United States and other countries using different use measures have found current smokers to be at least 15 times more likely to use VNPs than never smokers.
  • Adolescents and young adults who use VNPs are most likely to be those at higher risk of initiating cigarette smoking.
  • Young VNP experimenters are more likely to engage in other risky behaviors and have executive function deficits like those found in cigarette smokers. These findings suggest that a common liability model is more plausible than a gateway from VNP use to cigarette smoking.
  • Because VNPs are more widely available and often more appealing to smokers than conventional NRT, they have the potential for having a larger impact on the rate of smoking cessation in the population.
  • Concerns have been raised that cigarette smoking will be re-normalized by VNP use. This issue can be addressed by the media and public health campaigns that encourage norms that are hostile to cigarette smoking and at the same time distinguishing clearly between VNP and cigarette risks, discouraging dual use and encouraging exclusive VNP use.
  • The availability of VNPs may provide a justification for stronger policies to discourage cigarette smoking because smokers, particularly those of lower socio-economic status and with mental health issues, are given a less risky and potentially less costly alternative way to service their need for nicotine.
  • Cigarette companies that have entered the smokeless tobacco market have encouraged dual rather than exclusive use, and are likely to do the same with VNPs. By contrast, VNP companies that are unaffiliated with cigarette manufacturers want smokers to switch completely from cigarettes to VNPs.
  • Product content regulations that create regulatory hurdles that only large firms can surmount are likely to favor the cigarette industry and discourage innovation by firms outside the cigarette industry.
  • Cigarette companies do not control VNPs as they do the rest of the tobacco business; many manufacturers of e-cigarettes such as NJOY do not sell cigarettes, and there are thousands of vape shops that are independent of the cigarette industry
  • Retailer point-of-sale restrictions, which limit subsidies by cigarette manufacturers to provide shelf space and price promotions, can reduce price discounting and discourage advertisement displays. This could provide greater shelf space for VNP products to be sold by independent firms.
  • From a public health perspective, VNP policies should aim to discourage experimental and regular use of VNPs by never smokers who would not have smoked otherwise while encouraging innovations in VNP products that promote smoking cessation. The evidence suggests a strong potential for VNP use to improve population health by reducing or displacing cigarette use in countries where cigarette prevalence is high and smokers are interested in quitting.
  • The primary aim of tobacco control policy should therefore be to discourage cigarette use while providing the means for smokers to more easily quit smoking, even if that means switching for some time to VNPs rather than quitting all nicotine use.

The use of vaporized nicotine products (VNPs), especially e-cigarettes and, to a lesser extent, pressurized aerosol nicotine products and heat-not-burn tobacco products, are being adopted increasingly as an alternative to smoking combusted products, primarily cigarettes. Considerable controversy has accompanied their marketing and use. We propose a framework that describes and incorporates patterns of VNP and combustible cigarette use in determining the total amount of toxic exposure effects on population health. We begin by considering toxicity and the outcomes relevant to population health. We then present the framework and define different measures of VNP use; namely, trial and long-term use for exclusive cigarette smokers, exclusive VNP and dual (cigarette and VNP) use. Using a systems thinking framework and decision theory we considered potential pathways for current, former and never users of VNPs. We then consider the evidence to date and the probable impacts of VNP use on public health, the potential effects of different policy approaches and the possible influence of the tobacco industry on VNP and cigarette use.

– Content courtesy of No More Casualties and the Society For The Study Of Addiction

Facebooktwitterby feather
rssby feather

Nicotine without smoke


rcp-report

Today the Royal College of Physicians, the world’s oldest and most respected medical organization, has released a new 200 page report titled “Nicotine without smoke: Tobacco Harm Reduction” which concludes, among other things:

  • Smokers can be reassured and ENCOURAGED to use e-cigs, and the public can be reassured that e-cig are MUCH SAFER than smoking.
  • E-cigs are NOT a gateway to smoking.
  • E-cigs do NOT result in normalization of smoking.
  • Regulation should NOT be allowed to significantly inhibit the development and use of harm-reduction products by smokers.
  • E-cigs appear to be EFFECTIVE when used by smokers as an aid to QUITTING SMOKING.
  • E-cigs are marketed as consumer products and are proving MUCH MORE POPULAR than NRT as a substitute and COMPETITOR for tobacco cigarettes.
  • The hazard to health arising from long-term vapor inhalation is UNLIKELY TO EXCEED 5 PERCENT of the harm from smoking tobacco.
  • Evidence indicates that e-cigs are being used almost exclusively as SAFER ALTERNATIVES to smoked tobacco, by confirmed smokers who are trying to REDUCE HARM to themselves OR OTHERS from smoking, or to quit smoking completely.
  • In the interests of public health it is important to PROMOTE THE USE of e-cigs, NRT and other non-tobacco nicotine products as WIDELY as possible as a SUBSTITUTE for smoking in the UK.

This report aims to provide a fresh update on the use of harm reduction in tobacco smoking, in relation to all non-tobacco nicotine products but particularly e-cigarettes. It concludes that, for all the potential risks involved, harm reduction has huge potential to prevent death and disability from tobacco use, and to hasten our progress to a tobacco-free society.

A copy of the report can be downloaded here: Nicotine without smoke

Should you wish to discuss the report, the Utah Smoke Free Association is happy to discuss the findings at a time of your choosing. For any questions or concerns about any of the specific findings, we encourage you to reach out directly to the Royal College of Physicians or the UK Centre for Tobacco & Alcohol Studies  which is funded by the UK Clinical Research Collaboration who were the authors of the report.

We encourage all readers of this to forward this information to your legislators, mayors, city councils and health departments for their review and education.

Facebooktwitterby feather
rssby feather